| Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis S Singh, MH Murad, M Fumery, R Sedano, V Jairath, R Panaccione, ... The Lancet Gastroenterology & Hepatology 6 (12), 1002-1014, 2021 | 146 | 2021 |
| Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium B Shen, GS Kochhar, R Kariv, X Liu, U Navaneethan, DT Rubin, RK Cross, ... The lancet Gastroenterology & hepatology 6 (10), 826-849, 2021 | 87 | 2021 |
| Clinical trials of IL-12/IL-23 inhibitors in inflammatory bowel disease A Almradi, J Hanzel, R Sedano, CE Parker, BG Feagan, C Ma, V Jairath BioDrugs 34, 713-721, 2020 | 77 | 2020 |
| An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials C Ma, R Sedano, A Almradi, NV Casteele, CE Parker, L Guizzetti, ... Gastroenterology 160 (7), 2291-2302, 2021 | 69 | 2021 |
| Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium B Shen, GS Kochhar, DT Rubin, SV Kane, U Navaneethan, CN Bernstein, ... The Lancet Gastroenterology & Hepatology 7 (1), 69-95, 2022 | 56 | 2022 |
| Infecciones por Listeria monocytogenes, una experiencia de dos décadas: A two decade experience R Sedano, A Fica, D Guiñez, S Braun, L Porte, J Dabanch, T Weitzel, ... Revista chilena de infectología 30 (4), 417-425, 2013 | 34 | 2013 |
| Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week Dosing. R Sedano, L Guizzetti, C McDonald, V Jairath Clinical Gastroenterology and Hepatology: the Official Clinical Practice …, 2020 | 23 | 2020 |
| Manifestaciones clínicas y endoscópicas en enfermedad inflamatoria intestinal M Gompertz, R Sedano Revista Médica Clínica Las Condes 30 (4), 273-282, 2019 | 20 | 2019 |
| An approach to acute severe ulcerative colitis R Sedano, R Quera, D Simian, AJ Yarur Expert Review of Gastroenterology & Hepatology 13 (10), 943-955, 2019 | 19 | 2019 |
| An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials R Sedano, C Ma, RK Pai, G D'Haens, L Guizzetti, LM Shackelton, ... Alimentary Pharmacology & Therapeutics 53 (10), 1108-1117, 2021 | 18 | 2021 |
| Effectiveness of tofacitinib for hospitalized patients with acute severe ulcerative colitis: case series Y Xiao, N Benoit, R Sedano, V Jairath, N Narula, JD McCurdy, ... Digestive Diseases and Sciences 67 (11), 5213-5219, 2022 | 17 | 2022 |
| REMIT-UC: real-world effectiveness and safety of tofacitinib for moderate-to-severely active ulcerative colitis: a Canadian IBD Research Consortium Multicenter National Cohort … C Ma, R Panaccione, Y Xiao, Y Khandelwal, SK Murthy, ECL Wong, ... Official journal of the American College of Gastroenterology| ACG 118 (5 …, 2023 | 16 | 2023 |
| Janus kinase inhibitors for the management of patients with inflammatory bowel disease R Sedano, C Ma, V Jairath, BG Feagan Gastroenterology & hepatology 18 (1), 14, 2022 | 16 | 2022 |
| Underrepresentation of minorities and underreporting of race and ethnicity in Crohn’s disease clinical trials R Sedano, M Hogan, C Mcdonald, T Aswani-Omprakash, C Ma, V Jairath Gastroenterology 162 (1), 338-340. e2, 2022 | 16 | 2022 |
| The relationship between endoscopic and clinical recurrence in postoperative Crohn’s disease: a systematic review and meta-analysis A Ble, C Renzulli, F Cenci, M Grimaldi, M Barone, R Sedano, J Chang, ... Journal of Crohn's and Colitis 16 (3), 490-499, 2022 | 14 | 2022 |
| Clinical, endoscopic, and safety placebo rates in induction and maintenance trials of Crohn’s disease: meta-analysis of randomised controlled trials A Almradi, R Sedano, M Hogan, GY Zou, JK MacDonald, CE Parker, ... Journal of Crohn's and Colitis 16 (5), 717-736, 2022 | 13 | 2022 |
| Disease activity indices for pouchitis: a systematic review R Sedano, TM Nguyen, A Almradi, F Rieder, CE Parker, LM Shackelton, ... Inflammatory Bowel Diseases 28 (4), 622-638, 2022 | 13 | 2022 |
| Systematic review and meta-analysis: clinical, endoscopic, histological and safety placebo rates in induction and maintenance trials of ulcerative colitis R Sedano, M Hogan, TM Nguyen, J Chang, GY Zou, JK Macdonald, ... Journal of Crohn's and Colitis 16 (2), 224-243, 2022 | 13 | 2022 |
| Biomarcadores en enfermedad inflamatoria intestinal:¿ sabe cómo utilizarlos? E Pérez de Arce, R Sedano, R Quera Revista médica de Chile 148 (3), 362-370, 2020 | 11 | 2020 |
| High-dose rescue tofacitinib prevented inpatient colectomy in acute severe ulcerative colitis refractory to anti-TNF R Sedano, V Jairath Inflammatory Bowel Diseases 27 (5), e59-e60, 2021 | 9 | 2021 |
